Amgen takes 20% stake in Chinese biotech BeiGene for $2.7 billion – CNBC
Business News
- Amgen takes 20% stake in Chinese biotech BeiGene for $2.7 billion CNBC
- Amgen acquires stake in BeiGene to grow cancer drug business to China STAT
- Amgen to Take $2.7 Billion Stake in BeiGene for China Growth Yahoo Finance
- View full coverage on Google News
Source: Business News